Immunome logo

Immunome share price today

(IMNM)

Immunome share price is $11.2 & ₹961.07 as on 7 Jan 2025, 2.30 'hrs' IST

$11.2

-0.07

(-0.62%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Immunome share price in Dollar and Rupees. Guide to invest in Immunome stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Immunome, along with analyst recommendations, forecasts, and comprehensive financials.

Immunome share price movements

  • Today's Low: $11.04
    Today's High: $11.54

    Day's Volatility :4.33%

  • 52 Weeks Low: $8.97
    52 Weeks High: $30.96

    52 Weeks Volatility :71.03%

Immunome Returns

PeriodImmunome IncIndex (Russel 2000)
3 Months
-12.64%
0.0%
6 Months
-9.84%
0.0%
1 Year
-6.08%
0.0%
3 Years
-2.76%
-19.8%

Immunome Key Statistics

in dollars & INR

Previous Close
$11.27
Open
$11.46
Today's High
$11.54
Today's Low
$11.04
Market Capitalization
$662.9M
Today's Volume
$703.5K
52 Week High
$30.958
52 Week Low
$8.97
Revenue TTM
$10.1M
EBITDA
$-110.4M
Earnings Per Share (EPS)
$-7.94
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-276.36%

How to invest in Immunome from India?

It is very easy for Indian residents to invest directly in Immunome from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immunome stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immunome or IMNM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immunome or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immunome shares which would translate to 0.077 fractional shares of Immunome as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Immunome, in just a few clicks!

Returns in Immunome for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immunome investment value today

Current value as on today

₹96,556

Returns

₹3,444

(-3.44%)

Returns from Immunome Stock

₹6,667 (-6.67%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Immunome

200%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Immunome on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 200% more investors are searching Immunome in the last 30 days versus the previous period.

Global Institutional Holdings in Immunome

  • T. Rowe Price Investment Management,Inc.

    9.23%

  • Redmile Group, LLC

    7.83%

  • FMR Inc

    6.77%

  • EcoR1 Capital, LLC

    6.22%

  • BlackRock Inc

    6.02%

  • HHG PLC

    5.59%

Analyst Recommendation on Immunome

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Immunome(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Immunome

What analysts predicted

Upside of 167.86%

Current:

$11.20

Target:

$30.00

Insights on Immunome

  • Price Movement

    In the last 7 days, IMNM stock has moved up by 9.6%
  • IMNM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 22.4%
  • IMNM vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 60.2%
  • Price to Sales

    ForIMNM every $1 of sales, investors are willing to pay $59.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Immunome Technicals Summary

Sell

Neutral

Buy

Immunome is currently in a neutral trading position according to technical analysis indicators.

Immunome Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Immunome Inc
-22.44%
-9.84%
-6.08%
-2.76%
-16.21%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Immunome Inc
NA
NA
NA
-4.16
-2.76
-0.4
NA
4.97
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Immunome Inc
Buy
$662.9M
-16.21%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Immunome

immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. this proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. we then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.
Organization
Immunome
Employees
55
CEO
Dr. Clay B. Siegall Ph.D.
Industry
Health Technology

Management People of Immunome

NameTitle
Dr. Clay B. Siegall Ph.D.
President, CEO & Chairman
Dr. Jack Higgins Ph.D.
Chief Scientific Officer
Dr. Robert J. Lechleider M.D.
Chief Medical Officer
Mr. Max Rosett
Executive VP of Operations, Principal Accounting & Financial Officer and CFO
Dr. Philip Tsai
Chief Technical Officer
Ms. Sandra G. Stoneman Esq., J.D.
Chief Legal Officer, General Counsel & Corporate Secretary
Mr. Bruce Turner M.D., Ph.D.
Chief Strategy Officer
Mr. Kinney Horn
Chief Business Officer
Mr. Roee Shahar
Executive Vice President of Commercial

Important FAQs about investing in Immunome from India :

What is Immunome share price today?

Immunome share price today stands at $11.20, Open: $11.46 ; Previous Close: $11.27 ; High: $11.54 ; Low: $11.04 ; 52 Week High: $30.96 ; 52 Week Low: $8.97. The stock opens at $11.46, after a previous close of $11.27. The stock reached a daily high of $11.54 and a low of $11.04, with a 52-week high of $30.96 and a 52-week low of $8.97.

Can Indians buy Immunome shares?

Yes, Indians can invest in the Immunome (IMNM) from India.

With INDmoney, you can buy Immunome at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Immunome at zero transaction cost.

How can I buy Immunome shares from India?

It is very easy to buy Immunome from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immunome be purchased?

Yes, you can buy fractional shares of Immunome with INDmoney app.

What are the documents required to start investing in Immunome stocks?

To start investing in Immunome, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Immunome

Today’s highest price of Immunome (IMNM) is $11.54.

Today’s lowest price of Immunome (IMNM) is $11.04.

What is today's market capitalisation of Immunome

Today's market capitalisation of Immunome IMNM is 662.9M

What is the 52 Week High and Low Range of Immunome

  • 52 Week High

    $30.96

  • 52 Week Low

    $8.97

What are the historical returns of Immunome?

  • 1 Month Returns

    -22.44%

  • 3 Months Returns

    -9.84%

  • 1 Year Returns

    -6.08%

  • 5 Years Returns

    -16.21%

Who is the Chief Executive Officer (CEO) of Immunome

Dr. Clay B. Siegall Ph.D. is the current Chief Executive Officer (CEO) of Immunome.